These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 17517181
1. Expression of seprase in effusions from patients with epithelial ovarian carcinoma. Zhang MZ, Qiao YH, Nesland JM, Trope C, Kennedy A, Chen WT, Suo ZH. Chin Med J (Engl); 2007 Apr 20; 120(8):663-8. PubMed ID: 17517181 [Abstract] [Full Text] [Related]
3. Heparanase expression correlates with poor survival in metastatic ovarian carcinoma. Davidson B, Shafat I, Risberg B, Ilan N, Trope' CG, Vlodavsky I, Reich R. Gynecol Oncol; 2007 Feb 20; 104(2):311-9. PubMed ID: 17030350 [Abstract] [Full Text] [Related]
4. Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications. Davidson B, Risberg B, Berner A, Nesland JM, Tropé CG, Kristensen GB, Bryne M, Goscinski M, van de Putte G, Flørenes VA. Gynecol Oncol; 2001 Nov 20; 83(2):249-56. PubMed ID: 11606079 [Abstract] [Full Text] [Related]
5. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions. Davidson B, Berner A, Nesland JM, Risberg B, Kristensen GB, Tropé CG, Bryne M. Hum Pathol; 2000 Sep 20; 31(9):1081-7. PubMed ID: 11014575 [Abstract] [Full Text] [Related]
7. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma. Gorovetz M, Baekelandt M, Berner A, Trope' CG, Davidson B, Reich R. Gynecol Oncol; 2006 Dec 20; 103(3):831-40. PubMed ID: 16919315 [Abstract] [Full Text] [Related]
9. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity. Bar JK, Grelewski P, Popiela A, Noga L, Rabczyñski J. Gynecol Oncol; 2004 Oct 20; 95(1):23-31. PubMed ID: 15385106 [Abstract] [Full Text] [Related]
17. Different clinical roles for p21-activated kinase-1 in primary and recurrent ovarian carcinoma. Davidson B, Shih IeM, Wang TL. Hum Pathol; 2008 Nov 20; 39(11):1630-6. PubMed ID: 18656238 [Abstract] [Full Text] [Related]
18. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors. Sui L, Dong Y, Watanabe Y, Yamaguchi F, Sugimoto K, Tokuda M. Oncol Rep; 2006 Apr 20; 15(4):765-71. PubMed ID: 16525656 [Abstract] [Full Text] [Related]
19. Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China. Goscinski MA, Suo ZH, Nesland JM, Chen WT, Zakrzewska M, Wang J, Zhang S, Flørenes VA, Giercksky KE. Oncology; 2008 Apr 20; 75(1-2):49-59. PubMed ID: 18787344 [Abstract] [Full Text] [Related]
20. Differential expression of the 67 kilodalton laminin receptor in epithelioid malignant mesothelioma and carcinomas that spread to serosal cavities. Reich R, Vintman L, Nielsen S, Kaern J, Bedrossian C, Berner A, Davidson B. Diagn Cytopathol; 2005 Nov 20; 33(5):332-7. PubMed ID: 16240397 [Abstract] [Full Text] [Related] Page: [Next] [New Search]